CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway
Abstract Metastasis is the leading cause of treatment failure and tumor-related death in colorectal cancer (CRC). Our previous studies report that CEMIP functionally promotes CRC metastasis and is closely related to poor outcomes. However, the molecular network of CEMIP promoting CRC metastasis is s...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2023-02-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-023-05644-z |
| _version_ | 1827982545172561920 |
|---|---|
| author | Guojie Xu Lei Zhao Qingling Hua Lanqing Wang Hongli Liu Zhenyu Lin Min Jin Jing Wang Pengfei Zhou Kunyu Yang Gang Wu Dandan Yu Dejun Zhang Tao Zhang |
| author_facet | Guojie Xu Lei Zhao Qingling Hua Lanqing Wang Hongli Liu Zhenyu Lin Min Jin Jing Wang Pengfei Zhou Kunyu Yang Gang Wu Dandan Yu Dejun Zhang Tao Zhang |
| author_sort | Guojie Xu |
| collection | DOAJ |
| description | Abstract Metastasis is the leading cause of treatment failure and tumor-related death in colorectal cancer (CRC). Our previous studies report that CEMIP functionally promotes CRC metastasis and is closely related to poor outcomes. However, the molecular network of CEMIP promoting CRC metastasis is still not fully understood. In the current study, we identify CEMIP interacting with GRAF1, and the combination of high-CEMIP and low-GRAF1 predicts poor survival of patients. Mechanistically, we elucidate that CEMIP interacts with the SH3 domain of GRAF1 through the 295–819aa domain, and negatively regulates the stability of GRAF1. Moreover, we identify MIB1 to be an E3 ubiquitin ligase for GRAF1. Importantly, we uncover that CEMIP acts as a scaffold protein in bridging MIB1 and GRAF1, which is critical to GRAF1 degradation and CEMIP-mediated CRC metastasis. Furthermore, we found that CEMIP activates CDC42/MAPK pathway-regulated EMT by enhancing the degradation of GRAF1, which is indispensable to CEMIP-mediated migration and invasion of CRC cells. Subsequently, we prove that CDC42 inhibitor suppresses CEMIP-mediated CRC metastasis in vitro and in vivo. Collectively, our results reveal that CEMIP promotes CRC metastasis through GRAF1/CDC42/MAPK pathway-regulated EMT, and suggest that CDC42 inhibitor could be a novel therapeutic strategy for CEMIP-mediated CRC metastasis. |
| first_indexed | 2024-04-09T22:34:36Z |
| format | Article |
| id | doaj.art-12ab44a331d94663849d6243043a2a2d |
| institution | Directory Open Access Journal |
| issn | 2041-4889 |
| language | English |
| last_indexed | 2024-04-09T22:34:36Z |
| publishDate | 2023-02-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death and Disease |
| spelling | doaj.art-12ab44a331d94663849d6243043a2a2d2023-03-22T12:32:14ZengNature Publishing GroupCell Death and Disease2041-48892023-02-0114211210.1038/s41419-023-05644-zCEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathwayGuojie Xu0Lei Zhao1Qingling Hua2Lanqing Wang3Hongli Liu4Zhenyu Lin5Min Jin6Jing Wang7Pengfei Zhou8Kunyu Yang9Gang Wu10Dandan Yu11Dejun Zhang12Tao Zhang13Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan YZY Medical Science & Technology Co., LtdCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Metastasis is the leading cause of treatment failure and tumor-related death in colorectal cancer (CRC). Our previous studies report that CEMIP functionally promotes CRC metastasis and is closely related to poor outcomes. However, the molecular network of CEMIP promoting CRC metastasis is still not fully understood. In the current study, we identify CEMIP interacting with GRAF1, and the combination of high-CEMIP and low-GRAF1 predicts poor survival of patients. Mechanistically, we elucidate that CEMIP interacts with the SH3 domain of GRAF1 through the 295–819aa domain, and negatively regulates the stability of GRAF1. Moreover, we identify MIB1 to be an E3 ubiquitin ligase for GRAF1. Importantly, we uncover that CEMIP acts as a scaffold protein in bridging MIB1 and GRAF1, which is critical to GRAF1 degradation and CEMIP-mediated CRC metastasis. Furthermore, we found that CEMIP activates CDC42/MAPK pathway-regulated EMT by enhancing the degradation of GRAF1, which is indispensable to CEMIP-mediated migration and invasion of CRC cells. Subsequently, we prove that CDC42 inhibitor suppresses CEMIP-mediated CRC metastasis in vitro and in vivo. Collectively, our results reveal that CEMIP promotes CRC metastasis through GRAF1/CDC42/MAPK pathway-regulated EMT, and suggest that CDC42 inhibitor could be a novel therapeutic strategy for CEMIP-mediated CRC metastasis.https://doi.org/10.1038/s41419-023-05644-z |
| spellingShingle | Guojie Xu Lei Zhao Qingling Hua Lanqing Wang Hongli Liu Zhenyu Lin Min Jin Jing Wang Pengfei Zhou Kunyu Yang Gang Wu Dandan Yu Dejun Zhang Tao Zhang CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway Cell Death and Disease |
| title | CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway |
| title_full | CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway |
| title_fullStr | CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway |
| title_full_unstemmed | CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway |
| title_short | CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway |
| title_sort | cemip acting as a scaffold protein for bridging graf1 and mib1 promotes colorectal cancer metastasis via activating cdc42 mapk pathway |
| url | https://doi.org/10.1038/s41419-023-05644-z |
| work_keys_str_mv | AT guojiexu cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT leizhao cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT qinglinghua cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT lanqingwang cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT hongliliu cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT zhenyulin cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT minjin cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT jingwang cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT pengfeizhou cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT kunyuyang cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT gangwu cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT dandanyu cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT dejunzhang cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway AT taozhang cemipactingasascaffoldproteinforbridginggraf1andmib1promotescolorectalcancermetastasisviaactivatingcdc42mapkpathway |